Embecta Corp
Parsippany-Troy Hills, NJ Doing business as Berra Newco Inc.
- UEI
- NHDJR297RV75
- CAGE
- 9JVQ7
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 300 Kimball Dr #300, Parsippany-Troy Hills, NJ 07054, USA
- Website
- embecta.com
- Founded
- 2022
- Employees
- 1K-5K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 59 Miscellaneous Retail
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Cardinal Health 200, LLC | SPE2DV24FAW7S | $365 |
Similar vendors
About the company
Embecta Corp, doing business as Berra Newco Inc., is a global medical technology company focused on improving the lives of people with diabetes through the development and provision of solutions to the diabetes community. For nearly 100 years, Embecta has been a leader in insulin delivery devices.
Through past prime and sub federal contract awards, Embecta has provided medical and surgical supplies, including insulin syringes and pen needles, to Department of Veterans Affairs (VA) healthcare facilities. As a prime contractor, Embecta was awarded single-award indefinite delivery contracts from the VA National Acquisition Center for the procurement of over $46 million in insulin syringes and universal pen needles to supply VA, Department of Defense, Bureau of Prisons, and Indian Health Services outpatient pharmacies through 2024. Embecta also received a subcontract from Cardinal Health to provide medical and surgical equipment and supplies.
Embecta currently holds a prime Blanket Purchase Agreement awarded by the VA Veterans Health Administration Veterans Integrated Service Network 1 to procure medical and surgical supplies to support VA programs. The single-award BPA has an estimated potential value of $1 million and a ordering period spanning 2023-2028. Embecta also holds an indefinite delivery contract with no set-aside designations to provide insulin syringes to various federal agencies through 2028. These contract vehicles enable federal customers to efficiently issue orders to Embecta on an as-needed basis for diabetes care supplies.
Quick answers
Is Embecta Corp registered in SAM.gov?
Yes. Embecta Corp's SAM.gov registration is active through January 22, 2027.
What is Embecta Corp's CAGE code?
Embecta Corp's CAGE code is 9JVQ7, and its Unique Entity ID (UEI) is NHDJR297RV75.
On GovTribe
See Embecta Corp's full federal record
- IDV awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors